List Price: $80.00
Member Price: $61.00
Page Count: 224
As pharmacists see more obese patients and pharmacotherapy becomes increasingly complex, they need a resource that puts all the necessary information in one place and makes it easy to use. With Demystifying Drug Dosing in Obese Patients, that resource is here. Summary tables, examples, and sample calculations put practical information at practitioners’ fingertips. Content by nationally recognized authors—edited by credentialed practitioners who’ve been there—supports scientifically sound decisions.
As pharmacists see more obese patients and pharmacotherapy becomes increasingly complex, they need a resource that puts all the necessary information in one place and makes it easy to use.
With Demystifying Drug Dosing in Obese Patients, that resource is here, delivering:
Summary tables, examples, and sample calculations put practical information at practitioners’ fingertips. Content by nationally recognized authors—edited by credentialed practitioners who’ve been there—supports scientifically sound decisions.
Brandon R. Shank, PharmD, BCOP
Brandon R. Shank is a Clinical Pharmacy Specialist at the University of Texas MD Anderson Cancer Center and Adjunct Clinical Assistant Professor at Texas Southern University. Dr. Shank received his Doctor of Pharmacy degree from the Philadelphia College of Pharmacy. He completed a postgraduate year 1 pharmacy practice residency and postgraduate year 2 pharmacy residency, specializing in oncology at The Johns Hopkins Hospital. His practice area is inpatient and outpatient lymphoma, multiple myeloma, and stem cell transplantation. Dr. Shank is a Board Certified Oncology Pharmacist and has worked with a diverse patient population. He has several abstracts and peer-reviewed publications in the area of oncology and presented nationally.
David E. Zimmerman, PharmD, BCPS
David E. Zimmerman is an Assistant Professor of Pharmacy at the Mylan School of Pharmacy at Duquesne University and Emergency Medicine Clinical Pharmacist at the University of Pittsburgh Medical Center-Mercy Hospital. Dr. Zimmerman received his Doctor of Pharmacy degree from the Philadelphia College of Pharmacy. He completed his PGY1 pharmacy practice residency at The Johns Hopkins Hospital and his PGY2 emergency medicine residency at Maimonides Medical Center. He is a Board Certified Pharmacotherapy Specialist and has abstracts and peer-reviewed publications in the areas of emergency medicine and neurology. He is also involved in developing emergency medicine clinical pharmacy services outside of the United States.
An interview with the authors can be found here.
Please refer to the following correction notice for this publication: here